Open Access
Original contribution
Issue
Parasite
Volume 18, Number 4, November 2011
Page(s) 311 - 318
DOI https://doi.org/10.1051/parasite/2011184311
Published online 15 November 2011
  1. Agence Européenne Du Médicament. Résumé des caractéristiques produit, créé le 23/07/2009, consulté le 21/07/2011. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/veterinary/ 000084/WC500067490.pdf [Google Scholar]
  2. Beugnet F. & Marié J.L. Emerging arthropod-borne diseases of companion animals in Europe. Veterinary Parasitology, 2009, 163, 298–305. [CrossRef] [PubMed] [Google Scholar]
  3. Bourdoiseau G. Canine babesiosis in France. Veterinary Parasitology, 2006, 138, 118–125. [CrossRef] [PubMed] [Google Scholar]
  4. Giunchetti R.C., Correa-Oliveira R., Martins-Filho O.A., Teixeira-Carvalho A., Roatt B.M., de Oliveira Aguiarsoares R.D., de Souza J.V, das Dores Moreira N., Malaquias L.C., Mota E., Castro L.L., de Lana M. & Reis A.B. Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs. Vaccine, 2007, 25, 7674–7686. [CrossRef] [PubMed] [Google Scholar]
  5. Kensil C.R., Patel U., Lennick M. & Marciani D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. Journal of Immunology, 1991, 146, 431–437. [Google Scholar]
  6. Kjelgaard-Hansen M., Jensen A.L. & Kristensen A.T. Evaluation of a commercially available human C-reactive protein (CRP) turbidometric immunoassay for determination of canine serum CRP concentration. Veterinary Clinical Pathology, 2003, 32, 81–87. [CrossRef] [Google Scholar]
  7. Kuribayashi T., Shimada T., Matsumoto M., Kawato K., Honjyo T., Fukuyama M., Yamamoto Y. & Yamamoto S. Determination of serum C-reactive protein (CRP) in healthy beagle dogs of various ages and pregnant beagle dogs. Experimental Animals, 2003, 52, 387–390. [CrossRef] [Google Scholar]
  8. McGrotty Y.L., Knottenbelt C.M., Ramsey I.K., Reid S.W. & Eckersall P.D. Haptoglobin concentrations in a canine hospital population. Veterinary Record, 2003, 152, 562–564. [CrossRef] [Google Scholar]
  9. Muntener C.R., Bruckner L., Gassner B., Sturer A., Demuth D.C., Althaus F.R. & Zwahlen R. Reported adverse reactions due to veterinary drugs in 2006. Schweiz Arch Tierheilkd, 2007, 149, 439–448. [CrossRef] [PubMed] [Google Scholar]
  10. Nakamura M., Takahashi M., Ohno K., Koshino A., Nakashima K., Setoguchi A., Fujino Y. & Tsujimoto H. C-reactive protein concentration in dogs with various diseases. Journal of Veterinary Medical Science, 2008, 70, 127–131. [CrossRef] [Google Scholar]
  11. Parra L.E., Borja-Cabrera G.P. Santos F.N., Souza L.O., Palatnik-De-Sousa C. B. & Menz I. Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil. Vaccine, 2007, 25, 2180–2186. [CrossRef] [PubMed] [Google Scholar]
  12. Schetters T. Vaccination against canine babesiosis. Trends in Parasitology, 2005, 21, 179–184. [CrossRef] [PubMed] [Google Scholar]
  13. Schetters T.P., Kleuskens J.A., Scholtes N.C., Gorenflot A., Moubri K. & Vermeulen A.N. Vaccination of dogs against heterologous Babesia canis infection using antigens from culture supernatants. Veterinary Parasitology, 2001, 100, 75–86. [CrossRef] [PubMed] [Google Scholar]
  14. Schetters T.P., Kleuskens J.A., Scholtes N.C., van de Crommert J., Krijnen E., Moubri K., Gorenflot A. & Vermeulen A.N. Onset and duration of immunity against Babesia canis infection in dogs vaccinated with antigens from culture supernatants. Veterinary Parasitology, 2006, 138, 140–146. [CrossRef] [PubMed] [Google Scholar]
  15. Sibinovic K.H., Macleod R., Ristic M., Sibinovic S. & Cox H.W. A study of some of the physical, chemical, and serologic properties of antigens from sera of horses, dogs, and rats with acute babesiosis. Journal for Parasitology, 1967, 53, 919–923. [CrossRef] [Google Scholar]
  16. Skene C.D. & Sutton P. Saponin-adjuvanted particulate vaccines for clinical use. Methods, 2006, 40, 53–59. [CrossRef] [PubMed] [Google Scholar]
  17. Sun H.X., Xie Y. & Ye Y.P. Advances in saponin-based adjuvants. Vaccine, 2009, 27, 1787–1796. [CrossRef] [PubMed] [Google Scholar]
  18. Ulutas B., Bayramli G., Ulutas P.A. & Karagenc T. Serum concentration of some acute phase proteins in naturally occurring canine babesiosis: a preliminary study. Veterinary Clinical Pathology, 2005, 34, 144–147. [CrossRef] [Google Scholar]
  19. Waite D.C., Jacobson E.W., Ennis F.A., Edelman R., White B., Kammer R., Anderson C. & Kensil C.R. Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21. Vaccine, 2001, 19, 3957–3967. [CrossRef] [PubMed] [Google Scholar]
  20. Weidmeyer C.E., Solter P.F. Validation of human haptoglobin immunoturbidimetric assay for detection of haptoglobin in equine and canine serum and plasma. Veterinary Clinical Pathology, 1996, 25, 141–146. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.